Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samir Hanash

Showing results (131-140 of 169) with videos related to

Pageof 17
Sort By:
The American Journal of Pathology|October 28, 2003
Accurate molecular classification of human cancers based on gene expression using a simple classifier with a pathological tree-based frameworkKerby A Shedden, Jeremy M G Taylor, Thomas J Giordano, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 1, 2013
CDKN2A/p16 inactivation mechanisms and their relationship to smoke exposure and molecular features in non-small-cell lung cancerKit W Tam, Wei Zhang, Junichi Soh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Delineation, functional validation, and bioinformatic evaluation of gene expression in thyroid follicular carcinomas with the PAX8-PPARG translocationThomas J Giordano, Amy Y M Au, Rork Kuick, et al.
Oncogene|September 2, 2021
P4HA2-induced prolyl hydroxylation suppresses YAP1-mediated prostate cancer cell migration, invasion, and metastasisMing Zhu, Ruiqing Peng, Xin Liang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 5, 2025
The LEAP Study: A Multicenter Biospecimen and Imaging Resource for Lung Cancer ScreeningJennifer B Dennison, Sebastien Gendarme, Nicole M Kettner, et al.
The New England Journal of Medicine|August 9, 2013
ST2 as a marker for risk of therapy-resistant graft-versus-host disease and deathMark T Vander Lugt, Thomas M Braun, Samir Hanash, et al.
Nature Communications|August 29, 2020
Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancerJody Vykoukal, Johannes F Fahrmann, Justin R Gregg, et al.
Molecular Cancer Therapeutics|March 14, 2012
Quantitative proteomic profiling identifies protein correlates to EGFR kinase inhibitionKian Kani, Vitor M Faca, Lindsey D Hughes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 15, 2023
SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor-Induced Growth SuppressionChuandong Geng, Man-Chao Zhang, Ganiraju C Manyam, et al.
Cancers|July 24, 2021
Identification of Blood-Based Biomarkers for the Prediction of the Response to Neoadjuvant Chemoradiation in Rectal CancerDelphine Dayde, Jillian Gunther, Yutaka Hirayama, et al.
Pageof 17

Showing results (131-140 of 169) with videos related to

Sort By:
Pageof 17
The American Journal of Pathology|October 28, 2003
Accurate molecular classification of human cancers based on gene expression using a simple classifier with a pathological tree-based frameworkKerby A Shedden, Jeremy M G Taylor, Thomas J Giordano, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 1, 2013
CDKN2A/p16 inactivation mechanisms and their relationship to smoke exposure and molecular features in non-small-cell lung cancerKit W Tam, Wei Zhang, Junichi Soh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Delineation, functional validation, and bioinformatic evaluation of gene expression in thyroid follicular carcinomas with the PAX8-PPARG translocationThomas J Giordano, Amy Y M Au, Rork Kuick, et al.
Oncogene|September 2, 2021
P4HA2-induced prolyl hydroxylation suppresses YAP1-mediated prostate cancer cell migration, invasion, and metastasisMing Zhu, Ruiqing Peng, Xin Liang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 5, 2025
The LEAP Study: A Multicenter Biospecimen and Imaging Resource for Lung Cancer ScreeningJennifer B Dennison, Sebastien Gendarme, Nicole M Kettner, et al.
The New England Journal of Medicine|August 9, 2013
ST2 as a marker for risk of therapy-resistant graft-versus-host disease and deathMark T Vander Lugt, Thomas M Braun, Samir Hanash, et al.
Nature Communications|August 29, 2020
Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancerJody Vykoukal, Johannes F Fahrmann, Justin R Gregg, et al.
Molecular Cancer Therapeutics|March 14, 2012
Quantitative proteomic profiling identifies protein correlates to EGFR kinase inhibitionKian Kani, Vitor M Faca, Lindsey D Hughes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 15, 2023
SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor-Induced Growth SuppressionChuandong Geng, Man-Chao Zhang, Ganiraju C Manyam, et al.
Cancers|July 24, 2021
Identification of Blood-Based Biomarkers for the Prediction of the Response to Neoadjuvant Chemoradiation in Rectal CancerDelphine Dayde, Jillian Gunther, Yutaka Hirayama, et al.
Pageof 17